Insider Transactions in Q1 2022 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
17,703
-13.37%
|
$8,161,083
$461.16 P/Share
|
|
Mar 10
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
1,848
+5.83%
|
$242,088
$131.8 P/Share
|
|
Mar 03
2022
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
2,423
-56.02%
|
$1,121,849
$463.68 P/Share
|
|
Mar 03
2022
|
Ronald W Penczek CAO & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,559
+12.09%
|
$461,464
$296.81 P/Share
|
|
Mar 02
2022
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,645
-1.35%
|
$761,635
$463.49 P/Share
|
|
Mar 02
2022
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.54%
|
$206,498
$463.49 P/Share
|
|
Mar 02
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-1.73%
|
$228,259
$463.49 P/Share
|
|
Mar 02
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-0.75%
|
$50,930
$463.49 P/Share
|
|
Mar 02
2022
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-0.8%
|
$225,481
$463.49 P/Share
|
|
Mar 02
2022
|
John E Gallina EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
1,420
-2.47%
|
-
|
|
Mar 02
2022
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-0.71%
|
$191,219
$463.49 P/Share
|
|
Mar 02
2022
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-1.85%
|
$24,076
$463.49 P/Share
|
|
Mar 01
2022
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,498
+13.41%
|
-
|
|
Mar 01
2022
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,352
-15.18%
|
$6,923,752
$451.5 P/Share
|
|
Mar 01
2022
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
9,196
+14.32%
|
-
|
|
Mar 01
2022
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-15.34%
|
$1,609,168
$451.5 P/Share
|
|
Mar 01
2022
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,883
+29.89%
|
-
|
|
Mar 01
2022
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-7.01%
|
$86,141
$451.5 P/Share
|
|
Mar 01
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
10,465
+16.15%
|
-
|
|
Mar 01
2022
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
4,667
-20.55%
|
$2,104,817
$451.5 P/Share
|
|
Mar 01
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
3,969
+12.75%
|
-
|
|
Mar 01
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
804
-7.01%
|
$362,604
$451.5 P/Share
|
|
Mar 01
2022
|
Gloria M Mccarthy EVP & Chief Administrative Off |
BUY
Grant, award, or other acquisition
|
Direct |
10,465
+7.94%
|
-
|
|
Mar 01
2022
|
Gloria M Mccarthy EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct |
4,871
-8.76%
|
$2,196,821
$451.5 P/Share
|
|
Mar 01
2022
|
John E Gallina EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,157
+8.98%
|
-
|
|
Mar 01
2022
|
John E Gallina EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,162
-8.16%
|
$1,877,062
$451.5 P/Share
|
|
Mar 01
2022
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,175
+17.95%
|
-
|
|
Mar 01
2022
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-18.34%
|
$166,419
$451.5 P/Share
|
|
Feb 07
2022
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
2,763
-57.86%
|
$1,251,639
$453.48 P/Share
|
|
Feb 07
2022
|
Ronald W Penczek CAO & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,763
+15.58%
|
$674,172
$244.49 P/Share
|